UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.505

Sortiert nach

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4456-4462

2004

Volltextzugriff (PDF)

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5281-5293

2005

Volltextzugriff (PDF)

Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration‐QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers

Clinical and translational science, 2020-03, Vol.13 (2), p.325-336

2020

Volltextzugriff (PDF)

Patient characteristics and patterns of drug use for sleep complaints in the united states: Analysis of national ambulatory medical survey data, 1997–2002

Clinical therapeutics, 2006-07, Vol.28 (7), p.1044-1053

2006

Volltextzugriff (PDF)

Relationship between age, renal function and bone mineral density in the US population

Osteoporosis international, 2003-07, Vol.14 (7), p.570-576

2003

Volltextzugriff (PDF)

The Patient‐Centered Future of Clinical Pharmacology

Clinical pharmacology and therapeutics, 2020-01, Vol.107 (1), p.72-75

2020

Volltextzugriff (PDF)

Correction to Discovery of the Hemifumarate and (α‑l‑Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group

Journal of medicinal chemistry, 2018-04, Vol.61 (7), p.3237-3237

2018

Volltextzugriff (PDF)

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

Hepatology international, 2017-03, Vol.11 (2), p.199-208

2017

Volltextzugriff (PDF)

Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration

Pharmaceutical research, 2001-02, Vol.18 (2), p.166-170

2001

Volltextzugriff (PDF)

The effect of dosing regimen on the pharmacokinetics of risedronate

British journal of clinical pharmacology, 1999-10, Vol.48 (4), p.536-542

1999

Volltextzugriff (PDF)

Dose-Proportional Pharmacokinetics of Risedronate on Single-Dose Oral Administration to Healthy Volunteers

Journal of clinical pharmacology, 2000-03, Vol.40 (3), p.258-265

2000

Volltextzugriff (PDF)

Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group

Journal of medicinal chemistry, 1996-01, Vol.39 (1), p.10-18

1996

Volltextzugriff (PDF)

Risedronate gastrointestinal absorption is independent of site and rate of administration

Pharmaceutical research, 1998-02, Vol.15 (2), p.228-232

1998

Volltextzugriff (PDF)

Population PK modeling and exposure-response analyses of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) in the phase III DECISION trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6061-6061

2014

Volltextzugriff (PDF)

Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase

Archives of biochemistry and biophysics, 1989-02, Vol.269 (1), p.11-17

1989

Volltextzugriff (PDF)

Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase–mediated acetaldehyde oxidation by trans‐4‐hydroxy‐2‐nonenal

Hepatology (Baltimore, Md.), 1991-04, Vol.13 (4), p.728-734

1991

Volltextzugriff (PDF)

Phase i and pharmacodynamic study of the oral MEK inhibitor Cl-1040 in patients with advanced malignancies : Signal transduction

Journal of clinical oncology, 2005, Vol.23 (23), p.5281-5293

2005

Volltextzugriff (PDF)

The oxidation of α-β unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases

Toxicology and applied pharmacology, 1987-03, Vol.87 (3), p.403-410

1987

Volltextzugriff (PDF)

Dose-Proportional Pharmacokinetics of Risedronate on Single-Dose Oral Administration to Healthy Volunteers

Journal of clinical pharmacology, 2000-03, Vol.40 (3), p.258-265

2000

Volltextzugriff (PDF)

Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase–mediated acetaldehyde oxidation bytrans-4-hydroxy-2-nonenal

Hepatology (Baltimore, Md.), 1991-04, Vol.13 (4), p.728-734

1991

Volltextzugriff (PDF)

Future Innovation

Pharmaceutical Technology, 2012-07, Vol.36 (7), p.142

2012

Volltextzugriff (PDF)

Advances in Cryptology: CRYPTO 2008 : 28th Annual International Cryptology Conference, Santa Barbara, CA, USA, August 17-21, 2008. Proceedings

2008 edition., 2008

Volltextzugriff (PDF)

Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population

Journal of investigative dermatology, 2019-03, Vol.139 (3), p.583-590

2019

Volltextzugriff (PDF)

Ad-hoc, Mobile and Wireless Networks: 7th International Conference, ADHOC-NOW 2008 Sophia-Antipolis, France, September 10-12, 2008 Proceedings

2008 edition, 2008

Volltextzugriff (PDF)

Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice

PloS one, 2012-03, Vol.7 (3), p.e34233-e34233

2012

Volltextzugriff (PDF)

1 – 25 von 1.505

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(964)
Mit Volltextzugriff
(1.403)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(705)
EZB Electronic Journals Library
(602)
MEDLINE
(559)
Ebook Central Perpetual and DDA
(460)
eBooks on EBSCOhost
(407)
Journals@Ovid Full Text
(366)
Standalone journals
(356)
SpringerLink Series
(345)
Access via ScienceDirect (Elsevier)
(170)
Springer Journals
(156)
IngentaConnect Journals
(149)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(97)
Wiley Blackwell Single Titles
(94)
Oxford Journals
(76)
Nature
(68)
Oxford Journals 2020 Medicine
(64)
Wiley Online Library Full Collection 2018
(63)
APS: American Physical Society E-Journals (Physics)
(61)
PROLA
(58)
JSTOR
(52)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration‐QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers

Patient characteristics and patterns of drug use for sleep complaints in the united states: Analysis of national ambulatory medical survey data, 1997–2002

Relationship between age, renal function and bone mineral density in the US population

The Patient‐Centered Future of Clinical Pharmacology

Correction to Discovery of the Hemifumarate and (α‑l‑Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration

The effect of dosing regimen on the pharmacokinetics of risedronate

Dose-Proportional Pharmacokinetics of Risedronate on Single-Dose Oral Administration to Healthy Volunteers

Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group

Risedronate gastrointestinal absorption is independent of site and rate of administration

Population PK modeling and exposure-response analyses of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) in the phase III DECISION trial

Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase

Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase–mediated acetaldehyde oxidation by trans‐4‐hydroxy‐2‐nonenal

Phase i and pharmacodynamic study of the oral MEK inhibitor Cl-1040 in patients with advanced malignancies : Signal transduction

The oxidation of α-β unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases

Dose-Proportional Pharmacokinetics of Risedronate on Single-Dose Oral Administration to Healthy Volunteers

Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase–mediated acetaldehyde oxidation bytrans-4-hydroxy-2-nonenal

Future Innovation

Advances in Cryptology: CRYPTO 2008 : 28th Annual International Cryptology Conference, Santa Barbara, CA, USA, August 17-21, 2008. Proceedings

Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population

Ad-hoc, Mobile and Wireless Networks: 7th International Conference, ADHOC-NOW 2008 Sophia-Antipolis, France, September 10-12, 2008 Proceedings

Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice

Suchergebnisse filtern